B
BLTE
Belite Bio, Inc
143.35
-1.11-0.77%After Hours: 143.35 0.00 0.00%17:55 06/05 EDT
OPEN/PREV CLOSE137.34/136.85
TODAY RANGE135.36-139.00
VOL154.91K
MARKET CAP5.54B
52 WEEK RANGE56.10-200.00
AVG VOL (3M)173.10K
% TURNOVER0.39%
TURNOVER--
P/E (TTM)-52.2166
% RANGE2.66%
EPS(TTM)-2.6459
P/E(FORWARD)1,381.60
P/B6.96
BVPS19.85
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.05B
SHARES OUTSTANDING40.09M
NEXT EARNINGS08/10-08/14
FREE FLOAT22.07M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·06/02 14:10
These 10 mid-cap U.S. healthcare companies carry the market's most expensive valuations
Benzinga·06/01 13:08
Full Transcript: Belite Bio Q1 2026 Earnings Call
Dow Jones·05/26 17:35
Belite Bio Is Maintained at Outperform by Mizuho
Dow Jones·05/26 17:35
Belite Bio Price Target Cut to $215.00/Share From $223.00 by Mizuho
Benzinga·05/26 17:25
Mizuho Maintains Outperform on Belite Bio, Lowers Price Target to $215
TipRanks·05/26 15:41
Belite Bio price target lowered to $215 from $223 at Mizuho
Reuters·05/26 10:37
BELITE BIO INC <BLTE.O>: MIZUHO CUTS TARGET PRICE TO $215 FROM $223
TipRanks·05/26 09:55
Mizuho Securities Remains a Buy on Belite Bio, Inc. ADR (BLTE)
Reuters·05/26 07:31
U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy
NASDAQ·05/22 20:34
Belite Bio Enters Oversold Territory (BLTE)
Dow Jones·05/21 10:52
Belite Bio Price Target Maintained With a $200.00/Share by HC Wainwright & Co.
Same Industry
Name/Symbol
Change%
Price